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It is not uncommon for a 
clinician to be faced with a 
patient who presents with 
recurrent infections. This 
leads to the question whether 
there is an underlying immunodeficiency. 
Adult patients with recurrent infections may 
fall into one of three groups: 
• Patients presenting with recurrent
localised infections: it is mandatory to 
exclude an underlying predisposing, 
regional anatomical defect. 
• Patients with secondary immuno-
deficiency: it can be caused by an 
underlying disease or a complication of 
immune suppression (Table 1). 
• A wide variety of primary immuno-
deficiency diseases (PIDs) presenting in 
childhood can persist into adulthood, while 
rare disorders such as cystic fibrosis and 
chronic granulomatous disease (CGD) can 
present for the first time in adults. Primary 
immune disorders can also present for the 
first time in adulthood and the conditions 
most likely to be encountered are discussed 
briefly below. Autoimmunity and 
malignancy are commonly associated with 
PID because of the defective immunity 
associated with these conditions.
Defects in humoral 
immunity
Selective IgA deciency
There may be a partial reduction or a severe 
deficiency of serum immunoglobulin (Ig) A.[1] 
Patients may be asymptomatic or present 
with recurrent sinopulmonary infections, 
especially when associated with IgG 
subclass deficiency, and gastrointestinal 
(GIT) infections such as recurrent 
giardiasis. Drugs such as anticonvulsants 
and sulfasalazine may also cause IgA 
deficiency, which may be reversible on 
discontinuation of the medication. There 
is a higher incidence of allergic rhinitis, 
asthma, and autoimmune disorders, 
including cytopenias and systemic 
lupus erythematosus (SLE), and some 
patients may develop common variable 
immunodeficiency (CVID). Patients 
with severe IgA deficiency are at risk for 
anaphylactic transfusion reactions as a 
result of anti-IgA antibodies in their serum 
reacting with transfused IgA components. 
Abnormalities in serum IgM levels
Selective IgM deficiency is rare and can be an 
incidental finding in otherwise asymptomatic 
patients, or patients may present with 
recurrent respiratory infections with poly-
saccharide-containing organisms such as 
pneumococci and Haemophilus influenzae.[2,3] 
Asthma and allergic rhinitis are commonly 
associated, while fibromyalgia-like symptoms 
and autoimmunity also occur. Patients shown 
to have antigen-specific defects can benefit 
from immunoglobulin replacement. 
Patients with hyper-IgM usually present in 
childhood with PID – with elevated serum 
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Table 1. Acquired, secondary causes of immunodeficiency
• HIV infection
• Post-splenectomy
• Diabetes
• Chronic renal disease – especially nephrotic syndrome
• Chronic liver cirrhosis
• Haematological disorders: chronic lymphocytic leukaemia, myeloma
• Immune suppression due to radiation, cytotoxic and/or steroid therapy
• Malnutrition, vitamin and mineral deficiency (e.g. zinc deficiency)
• Autoimmune disorders, e.g systemic lupus erythematosus
• Intestinal lymphangiectasia resulting in immunoglobulin and lymphocyte loss
• Malignancy, including thymoma with hypogammaglobulinaemia – Good’s syndrome
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IgM but reduced IgG and IgA levels.[4] This 
is a genetically heterogeneous disorder but 
the essential defect is in CD40-mediated 
signalling, causing defective monocyte, B-cell 
and T-cell function. This results in recurrent 
bacterial and opportunistic infections due to 
Pneumocystis and Cryptosporidium organisms. 
Milder mutations rarely result in a less severe 
clinical course that may present later in life.[4]
Common variable immunodeciency 
CVID is the commonest primary, intrinsic 
disorder of antibody production in both 
children and adults. It is defined by a 
markedly reduced serum IgG with low 
IgA and/or IgM together with: (i) proven 
lack of specific IgG production following 
test immunisations; and (ii) exclusion of 
B-cell defects (e.g. IgG subclass deficiency) 
and haematological conditions (e.g. 
chronic lymphocytic leukaemia (CLL) and 
myeloma).[5]
CVID is a heterogeneous, clinically 
diverse disorder. Recurrent sinusitis, upper 
respiratory tract infections and pneumonia 
can lead to bronchiectasis. Complications 
include autoimmune cytopenias, enteropathy, 
and lymphoid malignancies.[6] Liver disease 
occurs; the most common finding is 
raised alkaline phosphatase due to nodular 
regenerative hyperplasia, which is commonly 
associated with idiopathic non-cirrhotic portal 
hypertension.[7,8] Hepatitis B and C infections, 
primary biliary cirrhosis, granulomatous liver 
disease and autoimmune-like liver disease 
are also found. Immunoglobulin replacement 
therapy protects against infection but does 
not prevent the other complications.[6]
IgG subclass deciency and specic 
antibody deciency 
Clinically significant IgG subclass deficiency 
requires a significant reduction in one or more 
IgG subclass concentrations, together with 
evidence of antibody dysfunction evidenced 
by recurrent infections, and an inadequate 
response to vaccine challenge.[9] Recurrent 
infections may occur despite normal total 
serum immunoglobulin and IgG subclass 
levels owing to specific antibody deficiency 
(SAD). This is confirmed by failure to 
respond to test vaccines. If sinopulmonary 
infections persist despite aggressive 
treatment of predisposing allergic rhinitis 
and asthma and prophylactic antibiotics, 
then immunoglobulin replacement therapy 
may be required in both IgG subclass 
deficiency and SAD.
Selective IgG deciency
Patients with recurrent infections and 
borderline serum IgG are commonly 
referred for immune evaluation. They 
may have allergic rhinitis and recurrent 
sinusitis, and are also often asthmatic, 
requiring significant steroid use. 
Chronic infections are usually poorly 
defined and accompanied by fatigue 
and a modest reduction in serum IgG 
of 5 - 7 g/L (normal range 7 - 16 g/L). 
Hypogammaglobulinaemia due to steroid 
use can be diagnosed by preservation 
of functional antibody production in 
the form of adequate baseline memory 
antibodies or a good response to test 
vaccinations. 
Defects in cellular 
immunity
Adult patients present far less commonly 
with primary defects in cellular immunity. 
Defective cellular immunity often 
accompanies hypogammaglobulinaemia in 
CVID. Patients with acquired antibodies 
to inteferon (IFN)-γ are increasingly 
described[10] and defects in the interleukin 
(IL)-12 or IFN- type 1 cytokine pathway can 
present with disseminated Mycobacterium 
avium or Salmonella infections.[11] 
Defects in phagocytosis
These have recently been reviewed[12] and 
are usually diagnosed in childhood cases of 
recurrent pyogenic infections, deep-seated 
abscesses and sepsis, but can also present 
in adults.
Immune investigations 
Table 2 shows the clinical presentations due 
to defects in the five main components of 
protective immunity, which can guide the 
clinician to the required diagnostic tests. 
Recurrent localised infections are invariably 
caused by defects in anatomical barriers, 
leading to chronic infections. Examples 
include base of skull fractures presenting 
with recurrent pneumococcal meningitis, 
urinary tract obstruction presenting with 
recurrent urinary infections, and recurrent 
sinusitis following previous extensive 
surgery that results in bacterial colonisation 
on abnormal mucosal surfaces. 
Defects in innate immunity can cause 
recurrent infections; the most commonly 
encountered example is recurrent viral 
infection (especially herpes) due to deficiency 
of natural killer (NK) cells.[13] Patients 
with deficiency of terminal complement 
components C7 - C9 present with recurrent 
Neisseria meningitidis meningitis. Defects 
in T-cell function present with typical 
opportunistic organisms, and fungal, 
parasitic and mycobacterial infections. 
Defects in phagocytic function can present 
with infections caused by non-pathogenic 
bacteria or fungi. Defects in antibody 
production present with recurrent upper 
respiratory, sinus and middle-ear infections; 
these are most commonly encountered in 
clinical practice.
Quantification of the major immuno-
globulin classes IgA, IgM, IgG and 
IgE is routinely requested as the initial 
investigation in cases of suspected 
humoral immuno deficiency. Where pan-
hypogammaglobulinaemia is documented, 
myeloma needs to be excluded with serum 
protein electrophoresis, free serum light-
chain assay, and urine light chains. Where 
immunoglobulin levels are low/normal and/
or an IgG subclass deficiency is suspected, 
it is customary to request IgG subclasses, 
but minor reductions below the laboratory 
normal values are frequently misinterpreted 
as significant. For a clinically relevant 
IgG subclass deficiency there needs to be 
significant reduction in values and it is 
preferable to consider the subclass per centage 
distribution rather than absolute values. As a 
general rule, IgG1 >60%, IgG2 >10 - 15%, IgG3 
>5%, while IgG4 can be absent in a significant 
number of normal people. Functional capacity 
of humoral immunity is also more valuable 
than serum IgG quantification; therefore 
a baseline vaccination status is obtained 
by requesting serum IgG ‘memory’-
specific antibody levels against capsular 
polysaccharides of pneumococcus and 
Table 2. Clinical picture associated with defective function of specific compartments of 
the immune system
Defective immune function Clinical picture
B cell Recurrent upper respiratory tract infection/pneumonia
T cell Viral/protozoal/fungal/mycobacterial infection
Natural killer cell Recurrent viral
Phagocytosis Supurative skin or systemic infection
Complement Infections/autoimmunity
Anatomical defect Localised infections
NB: Recurrent localised infections are generally associated with an anatomical abnormality, and not defective immunity. 
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H. influenzae B, and against tetanus toxoid 
and diphtheria as representative of protein 
antigens. If these values are low, the response 
to vaccination with pneumococcus and 
tetanus-conjugated H. influenzae B (e.g. 
Hiberix vaccine) is evaluated after 3 - 4 
weeks. If defects in phagocytic function are 
suspected, this can be evaluated by flow 
cytometry to measure phagocytic index and 
respiratory burst of polymorph neutrophils 
and monocytes. A full evaluation includes 
assessment of bacterial killing and leukocyte 
chemotaxis. Measurement of peripheral 
blood subsets provides information on 
the percentage and absolute numbers of 
circulating T cell, B cell and NK cells, and 
is currently performed as a single platform 
by flow cytometry (Fig. 1). Where CVID 
is suspected, measurement of memory 
B-cell subsets is of value, as a reduction 
in ‘switched’ memory B cells correlates 
with recurrent respiratory infections and 
bronchiectasis,[14] more than actual serum 
immunoglobulin concentration.[15] T-cell 
function can be assessed by measuring 
proliferative responses to stimulation by 
mitogens (phytohaemagglutinin/Con-A or 
phorbal ester/ionomycin), antigens (purified 
protein derivative) and Candida. Where 
proliferative responses are normal and 
an inhibitor of IFN-γ is suspected, such 
as in disseminated avium infection in an 
otherwise normal individual, it is imperative 
to specifically test for a serum autoantibody 
against IFN-γ.[10] 
Management
General principles for the management of
patients with recurrent infections include:
• Optimal management of any predisposing 
conditions such as allergic rhinitis and
asthma, including allergy evaluation and
trigger avoidance, and use of nasal and
inhaled steroids.
• Prompt diagnosis and antibiotic therapy of
sinopulmonary infections to prevent chronic 
lung damage from recurrent infections,
which can result in bronchiectasis.
Bacterial infections should be confirmed,
where possible, by complete blood counts,
C-reactive protein levels and culturing. 
• Patients with poor memory polysaccharide 
antibody responses should receive
vaccination with conjugated 13-valent
pneumococcal vaccine (Prevnar).
• If repeated infections occur despite
the above measures a six-month trial
of prophylactic antibiotics should be
considered. 
• In patients with normal or low-normal
immunoglobulin levels with recurrent
infections, immunoglobulin replacement 
therapy (subcutaneous (SC) or intra-
venous (IV) infusion) is generally 
reserved for those with demonstrated 
suboptimal responses to vaccination with 
polysaccharide and protein antigens[16] 
and failed antibiotic prophylaxis, as 
treatment is costly, can be associated 
with side-effects, and is usually lifelong. 
• Patients with CVID need weekly SC or
monthly intravenous immunoglobulin
replacement. They may suffer from giardiasis 
due to IgA deficiency, which cannot be
replaced, and resultant malabsorption. They 
are best managed by a multidisciplinary
team consisting of a clinical immunologist,
pulmonologist and gastroenterologist. 
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Fig. 1. Flow cytometry demonstrating total absence of B cells in a 16-year-old adolescent who presented 
with severe necrotising pneumonia and extremely low serum immunoglobulins owing to X-linked 
agammaglobulinaemia. CD3+ identi es T cells; CD16+56+ identi es natural killer cells; CD19+ identi es 
B cells; and CD45+ identi es all leukocytes and is used to ‘gate’ on the lymphocyte population. (CD = 
clusters of di erentiation; Abs Cnt = absolute counts; SSC-H = side scatter, as indication of cell granular 
content, NK cells = natural killer cells; XLA = X-linked agammaglobulinaemia.)
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pneumococcus and H. influenzae B, and
against tetanus toxoid and diphtheria as
representative of protein antigens. If these 
values are low, the response to vaccination 
with pneumococcus and tetanus-conjugated 
H. influenzae B (e.g. Hiberix vaccine) is 
evaluated after 3 - 4 weeks. If defects in 
phagocytic function are suspected, this can 
be evaluated by flow cytometry to measure 
phagocytic index and respiratory burst of 
polymorph neutrophils and monocytes.
A full evaluation includes assessment of
bacterial killing and leukocyte chemotaxis. 
Measurement of peripheral blood subsets 
provides information on the percentage and 
absolute umbers of circulating T cell, B cell 
and NK cells, and is currently performe  
as a single platform by flow cytometry
(Fig. 1). Where CVID is suspected,
measurement of memory B-cell subsets
is of valu , as a reduction in ‘swit hed’
memory B cells correlates with recurrent 
respi atory i fections and bronchiectasis,[14]
more than actual serum immunoglobulin 
concentration.[15] T-cell function can
be assessed by measuring proliferative
responses to stimulation by mitogens
(phytohaemagglutinin/Con-A or phorbal 
ester/ionomycin), antigens (purified protein 
derivative) and Candida. Where proliferative 
responses are normal and an inhibitor of 
IFN-γ is suspected, such as in disseminated 
avium infection in an otherwise normal
individual, it is imperative to specifically test 
for a serum autoantibody against IFN-γ.[10]
Management
General principles for the management of 
patients with recurrent infections include:
• Optimal management of any predisposing 
conditions such as allergic rhinitis and 
asthma, including allergy evaluation and 
trigger avoidance, and use of nasal and 
inhaled steroids.
• Prompt diagnosis and antibiotic therapy of
sinopulmonary infections to prevent chronic
lu g da age from recurrent infections,
which can result in bronchiectasis.
Bacterial infections should e conf rmed,
wher  possible, by complete lood counts,
C-r active protein levels and culturing.
• Pati nts with poor memory polysaccharide 
an body resp nses should receive
vaccination with conjugated 13-valent
pneumoc ccal vaccine (Prevnar).
• If repeated infections occur despite
the above measures a six-month trial
of prophylactic antibiotics should be
considered. 
• In patients with normal or low-normal
immunoglobulin levels with recurrent
infections, immunoglobulin replacement
therapy (subcutaneous (SC) or intra-
venous (IV) infusion) is generally
reserved for those with demonstrated
suboptimal responses to vaccination with
polysaccharide and protein antigens[16]
and failed antibiotic prophylaxis, as
treatment is costly, can be associated
with side- ffects, and is us ally ifelong.
• Patients with CVID need weekly SC or
monthly intravenous im unoglobulin 
replacement. They may suffer from giardias s
due to IgA deficiency, which cannot be
replaced, and resultant malabsorption. They
are best managed by a multidisciplinary
team consisting of a clinical im unologist,
pulmonologist and gastroenterologist.
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Fig. 1. Flow cytometry demonstrating total absence of B cells in a 16-year-old adolescent who presented 
with severe necrotising pneumonia and extremely low serum immunoglobulins owing to X-linked 
agammaglobulinaemia. CD3+ identies T cells; CD16+56+ identies natural killer cells; CD19+ identies
B cells; and CD45+ identies all leukocytes and is used to ‘gate’ on the lymphocyte population. (CD = 
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content, NK cells = natural killer cells; XLA = X-linked agammaglobulinaemia.)
